Find out all about your favorite commercial!

TV spots

TV commercials Brilinta

Brilinta TV Spot, 'Everything Changed' Featuring Bob Harper
Brilinta TV Spot, 'I Survived'
Brilinta TV Spot, 'Survivor' Featuring Bob Harper
Brilinta TV Spot, 'Today, Tomorrow and Every Day'
Brilinta TV Spot, 'We Are Survivors'
Advertisers

Advertisers of commercials featuring Brilinta

Brilinta tv commercials
Brilinta

Brilinta is not a company, but rather a medication developed by the pharmaceutical company AstraZeneca. Brilinta, also known by its generic name ticagrelor, is an oral antiplatelet medication used in...

Actors

Actors who starred in Brilinta commercials

Bob Harper photo
Bobby Stewart photo
Frankie Amoroso photo
Kathleen Garrett photo
Kevin Collins photo
Malaika Jackson-Wright photo
Nancy Meyer photo
Shar Levine photo
Vince Cefalu photo
Agenices

Agencies worked with Brilinta

Brilinta tv commercials
Healix
Collaborated with Brilinta
Brilinta tv commercials
Patients & Purpose
Collaborated with Brilinta

What is Brilinta?

Brilinta tv commercials

Brilinta (ticagrelor) is a medication used to prevent blood clots in people with acute coronary syndrome (ACS) or a history of heart attack. It belongs to a class of drugs known as antiplatelet agents, which work by preventing platelets in the blood from sticking together and forming clots.

Mechanism of ActionBrilinta acts by inhibiting a specific receptor called P2Y12 on the platelet cell surface. By blocking this receptor, Brilinta prevents the activation and aggregation of platelets, thereby reducing the risk of clot formation in the arteries.

Uses and IndicationsBrilinta is primarily prescribed to people with ACS, including those with unstable angina or myocardial infarction (heart attack), to reduce the risk of future cardiovascular events. It is typically used in combination with aspirin to provide dual antiplatelet therapy.

Efficacy and SafetySeveral clinical studies have demonstrated the efficacy of Brilinta in reducing the risk of cardiovascular events, such as heart attack, stroke, or cardiovascular death, compared to other antiplatelet agents. Brilinta has shown superiority over the commonly used drug, clopidogrel (Plavix), in terms of preventing cardiovascular events in ACS patients.

As with any medication, Brilinta comes with potential side effects. The most common side effects include bleeding, such as nosebleeds, bruising, or gastrointestinal bleeding. It is important for patients taking Brilinta to follow their healthcare provider's instructions and report any significant bleeding or other adverse effects promptly.

Dosage and AdministrationBrilinta is typically initiated with a loading dose of 180 mg, followed by a maintenance dose of 90 mg twice daily. The recommended duration of treatment varies depending on the patient's condition and the healthcare provider's judgment.

It is worth noting that Brilinta may interact with other medications, especially those that affect blood clotting. Therefore, it is essential for patients to inform their healthcare provider about all the medications they are taking to avoid potential drug interactions.

ConclusionBrilinta (ticagrelor) is an antiplatelet medication commonly used in the management of acute coronary syndrome to reduce the risk of further cardiovascular events. It works by inhibiting platelet aggregation, thereby preventing blood clot formation. While Brilinta has demonstrated efficacy in clinical studies, it is important for patients to be aware of potential side effects and to use the medication under the guidance of a healthcare professional.

Frequently Asked Questions about brilinta

BRILINTA is a prescription medicine for adults used to: decrease your risk of death, heart attack, and stroke in people with a blockage of blood flow to the heart (acute coronary syndrome or ACS) or a history of a heart attack.

BRILINTA is an oral antiplatelet that can help protect you from having another heart attack. BRILINTA is taken with a low-dose aspirin, no more than 100 mg, as it affects how well BRILINTA works.

IMPORTANT SAFETY INFORMATION ABOUT BRILINTA® (ticagrelor), INCLUDING BOXED WARNINGS, FOR 60-MG AND 90-MG TABLETS Read More. BRILINTA is used to lower your chance of having, or dying from, a heart attack or stroke, but BRILINTA (and similar drugs) can cause bleeding that can be serious and sometimes lead to death.

BRILINTA 90 mg tablets for oral administration contain 90 mg of ticagrelor and the following ingredients: mannitol, dibasic calcium phosphate, sodium starch glycolate, hydroxypropyl cellulose, magnesium stearate, hydroxypropyl methylcellulose, titanium dioxide, talc, polyethylene glycol 400, and ferric oxide yellow.

BRILINTA 60 MG + ASPIRIN WAS PROVEN TO WORK BETTER THAN ASPIRIN ALONE. BRILINTA + aspirin helped protect more patients from having a heart attack or stroke or dying from a cardiovascular event than aspirin alone.

The people took aspirin with either Brilinta or clopidogrel (Plavix). Over the course of 1 year, people taking the Brilinta combination had a 16% lower risk of heart attack, stroke, and death caused by heart problems than did people taking the clopidogrel combination.

Brilinta is considered stronger and faster-acting than Plavix, but comes with a higher risk of bleeding. Brilinta and Plavix are both effective at preventing blood clots. But Brilinta is known for its strong and rapid antiplatelet effects.

BRILINTA 60 MG + ASPIRIN WAS PROVEN TO WORK BETTER THAN ASPIRIN ALONE. BRILINTA + aspirin helped protect more patients from having a heart attack or stroke or dying from a cardiovascular event than aspirin alone.

Brilinta and Plavix are both effective at preventing blood clots. But Brilinta is known for its strong and rapid antiplatelet effects. In studies, it started working faster than Plavix and had a greater blood thinning effect, too. These effects are a good thing when it comes to preventing blood clots.

Brilinta (ticagrelor) and Plavix (clopidogrel) are antiplatelet medications used to prevent blood clots. Brilinta is taken twice a day, and Plavix is taken once a day. They're both often taken with low-dose aspirin. Brilinta and Plavix are both effective at preventing blood clots.

Brilinta is considered stronger and faster-acting than Plavix, but comes with a higher risk of bleeding. Brilinta and Plavix are both effective at preventing blood clots. But Brilinta is known for its strong and rapid antiplatelet effects.

Brilinta is an antiplatelet drug, which is different than an anticoagulant drug, such as warfarin.

Official answer. Brilinta is typically used for 6 to 12 months, or longer, after a stent or heart attack. It is given with low-dose aspirin to help prevent blood clots. Based on your use, you may receive Brilinta for different amounts of time.

Plavix 300 mg to 600 mg initial dose given, followed by 75 mg once daily. At the end of the 1-year study, BRILINTA 90 mg + aspirin was proven to work better than Plavix + aspirin by helping to protect more patients from having a heart attack or stroke or dying from a cardiovascular event.

More people treated with BRILINTA experienced bleeding compared to those treated with Plavix. Of people given BRILINTA 90 mg + aspirin, 3.9% (362/9,235) experienced bleeding‡ that was serious or sometimes fatal, compared to 3.3% (306/9,186) of people given Plavix + aspirin.

Brilinta (ticagrelor) appears to be slightly more effective than Plavix (clopidogrel) in reducing the percentage of CV death, MI or stroke in the first year of treatment. Brilinta patients had more breathing difficulties as a side effect compared to Plavix patients.

Goods

Other goods

Delaro Complete Fungicide logo
Nurtec Nurtec ODT logo
Massage Envy Membership logo
2013 Twentieth Century Studios The Counselor logo
Roku Roku 3 logo
Old Spice Fresher Collection Timber logo
Old Spice Bearglove logo
Taco Bell $5 Cravings Deal logo
Acceleron Seed Applied Solutions NemaStrike Seed Treatment logo
Blue Diamond Almonds Traditional Whole Natural logo
Blue Diamond Almonds Bold Wasabi and Soy Sauce logo
Blue Diamond Almonds Bold Smokehouse logo